![James Jeffery Mulchahey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Jeffery Mulchahey
Consejero General en Phase 2 Discovery, Inc. .
Origen de la red de primer grado James Jeffery Mulchahey.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Phase 2 Discovery, Inc.
![]() Phase 2 Discovery, Inc. Pharmaceuticals: MajorHealth Technology Phase 2 Discovery, Inc. (P2D) develops central nervous system drugs. The company provides discovery research & development services for pharmaceutical and biotechnology companies. It also develops drugs for treating psychiatric and neurologic disorders. Its products include PD6735, the treatment of primary insomnia and additional indications, N-Substituted Analogs of Benztropine for the treatment of attention deficit hyperactivity disorder & Thiothalidomides and Hydroxythalidomides for the treatment of ALS and MS. Phase 2 Discovery was founded in 1998 and is headquartered in Cincinnati, OH.
4
| Private Company | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a James Jeffery Mulchahey a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
University of Cincinnati (Ohio) | College/University | Corporate Officer/Principal | |
Villanova University | College/University | Graduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aventis, Inc. | Corporate Officer/Principal | ||
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
RxDino LLC
![]() RxDino LLC Pharmaceuticals: MajorHealth Technology RxDino LLC operates as a dermatology pharmaceutical company. The firm develops skin products for the treatment of dermatitis, rash, eczema, itchy, irritated skin, and allergies to plants and chemicals, such as poison ivy. It provides Over-the-counter topical hydrocortisone ointment with a formulation containing dehydroepiandrosterone as an emollient that enables hydrocortisone to be effective. The company is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Founder |
Estadísticas
Internacional
Estados Unidos | 7 |
Reino Unido | 2 |
Sectorial
Consumer Services | 4 |
Health Technology | 4 |
Operativa
Corporate Officer/Principal | 5 |
Director/Board Member | 2 |
Chairman | 1 |
President | 1 |
Chief Executive Officer | 1 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- James Jeffery Mulchahey
- Conexiones Empresas